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Brief Definitive Report

Type I Interferon Sensitizes Lymphocytes to Apoptosis
and Reduces Resistance to Listeria Infection
Javier A. Carrero, Boris Calderon, and Emil R. Unanue
Department of Pathology and Immunology,Washington University School of Medicine, St. Louis, MO 63110

Infection with Listeria monocytogenes causes lymphocyte apoptosis that is mediated by the actions
of the pore-forming virulence factor listeriolysin O (LLO). Previous work showed that activated
lymphocytes were highly sensitive to LLO-induced apoptosis, whereas resting lymphocytes
were less susceptible. We now show that mice deficient in the type I interferon (IFN) receptor
were more resistant to Listeria infection and had less apoptotic lesions than wild-type counterparts. Furthermore, treatment of resting splenic lymphocytes with recombinant IFN-A enhanced their susceptibility to LLO-induced apoptosis. Together, these data suggest that type I
IFN signaling is detrimental to handling of a bacterial pathogen and may enhance the susceptibility of lymphocytes undergoing apoptosis in response to bacterial pore-forming toxins.
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Introduction
Previous studies with Listeria monocytogenes have exposed
the role of multiple cytokines at different stages of the infection using gene-ablated mice or neutralizing monoclonal antibodies (for review see references 1 and 2). IL-12,
TNF, and the IL-1 family of proteins participate in activating different cells and controlling Listeria growth. These
early cytokines contribute to the induction of IFN-, a
product of NK and T cells, and activation of macrophages.
Much is known about the role of type I IFNs (IFN-
and IFN-) in the antiviral response and type II IFN (IFN-)
in the antiviral and antibacterial response (3–6). However,
there exists a paucity of data on the role of type I IFNs during bacterial infection. Here we report that the absence of
the shared IFN-/ receptor (IFN-R/) provides mice
with an advantage during Listeria infection. This resistance
was accompanied by an amelioration of the lymphocyte
apoptotic process that took place during the early exponential growth of Listeria in tissues.
We and others have described an early transitory phase of
lymphocyte apoptosis in infective foci that peaks at 48 h after infection (7, 8). Experiments ex vivo indicated that listeriolysin O (LLO), a pore-forming molecule and major virulence factor, caused lymphocyte apoptosis particularly in
cells that were replicating (9). Moreover, injection of pure
LLO subcutaneously led to lymphocyte apoptosis in the T
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cell–rich zones of draining lymph nodes. Of note is that
during the in vivo infection the apoptotic lesions were either not affected or were increased in mice in which IL-1,
IL-12, or IFN- were either neutralized or not produced
(7). The lesions were unrelated to activation-induced cell
death, to Fas–Fas ligand interactions, or to the production of
reactive oxygen or nitrogen intermediates. In toto the evidence points to the release of soluble LLO during the early
robust growth of Listeria as the mechanism leading to the
apoptotic death of lymphocytes in infective foci. In fact,
neutralization of LLO by injection of monoclonal antibody
to LLO controlled the infection as well as the intensity of
the apoptotic lesions (10). The data presented herein suggests that type I IFN sensitizes lymphocytes to undergo
apoptosis during Listeria infection, and that this has a negative effect on bacterial handling in the mouse.

Materials and Methods
Mice and Listeria Infection. Wild-type and IFN-R/ mice
on the 129Sv/Ev genetic background were provided by H.W.
Virgin IV (Washington University School of Medicine, St. Louis,
MO; reference 3). L. monocytogenes strain EGD was used as before
for intraperitoneal infection (7). Histological examination of hematoxylin and eosin– and TdT-mediated dUTP nick-end labeling (TUNEL)-stained sections was performed on the spleens
from infected mice (7). Cytometric bead array (CBA) analysis
was performed with the Mouse Inflammation Kit and used according to the manufacturer’s instructions with 50 L serum per
assay (BD Biosciences). CBA data was analyzed on a FACSCalibur™ with CELLQuest™ software and the CBA analysis soft-
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ing splenocytes, cells were also stained with anti–CD3-APC (BD
Biosciences) to identify T cells.

Results and Discussion
Listeria Infection. Infection of 129Sv/Ev mice with Listeria showed the expected increase in the number of organisms in the spleen and liver as a function of time (Fig. 1, A
and B). IFN-R/ mice had the same number of Listeria
as wild-type mice 24 h after infection. Therefore, there was
no difference between the two strains during the initial innate resistance to infection, which was mediated by neutrophils and macrophages (1). However, at 48 h after infection, there was about a 20-fold increase in CFUs in both
the spleens and livers of wild-type versus IFN-R/
mice. By 96 h after infection, IFN-R/ mice had no
further Listeria growth and showed 1,200-fold fewer
CFUs per organ (Fig. 1, A and B).
At 48 h after infection, the peak time at which lymphocyte apoptosis was evident, histological examination showed
a marked difference between both sets of mice (Fig. 2). The
difference in lymphocyte apoptosis was seen at three different infectious doses (Table I). Wild-type mice showed infective foci around the periarteriolar lymphoid sheath, characterized by a paucity of lymphocytes and the presence of

Figure 1. Bacterial burden and cytokine profile of
129Sv/Ev and IFN-R mice infected with L. monocytogenes. Mice were infected with 2.5  104 Listeria intraperitoneally and at the indicated days after infection (P.I.).
CFUs were assessed in the spleen (A) and liver (B). Serum
CBA analysis was performed on the same mice to yield serum concentrations of IL-6 (C), TNF- (D), IFN- (E),
and IL-12 (F). Bars represent the means  the SEM of at
least two independent experiments with a total number of
five to seven mice per group.
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ware package (BD Biosciences). For flow cytometric staining,
portions of spleens from infected mice were disrupted to generate
single cell suspensions. Cells were then stained for CD69 and either CD4 or CD8 using conventional techniques. All antibodies
were obtained from BD Biosciences.
Cell Cultures. A CD4 T cell line reactive to ovalbumin was
generated from normal 129Sv/J mice (The Jackson Laboratory)
immunized with an ovalbumin emulsion in complete Freund’s
adjuvant using previously described techniques (9). The line was
passaged every 10–12 d by the addition of irradiated 129Sv/J
splenocytes (3,000 rads), 10 M ovalbumin, and 50 U/ml IL-2.
The usual behavior was that of proliferation that slowly stopped
by about day 8. On day 10 after stimulation, the T cells were harvested and were not in cell cycle. Assays with the T cell line were
performed as described previously (9). Whole splenocytes were
isolated from 129Sv/Ev or IFN- R/ mice. Single cell suspensions were made and cells were plated at a density of 5  106
cells/ml in DMEM and 10% FCS, and treated with recombinant
mouse IFN-A at 1, 10, or 100 U/ml (specific activity: 4.8 
107 U/mg; PBL Biomedical Laboratories). Cells were incubated
for 24 h, and then the nonadherent cells were removed and purified. Both the T cell line and the splenocytes were purified over a
Histopaque 1119 gradient (Sigma-Aldrich). After Histopaque,
cells were resuspended in DMEM containing 1% FCS, and then
treated with 250 ng/ml of purified recombinant LLO (4.4 nM)
for 6 h. Cells were stained with annexin V-PE and 7-AAD (BD
Biosciences), and analyzed by flow cytometry. For assays involv-
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macrophages and neutrophils. Abundant TUNEL round
nuclei were evident (Fig. 2 B). (Previous histochemical and
ultrastructural studies have shown these TUNEL cells to
be lymphocytes [7]). At the highest infectious dose tested
(5  104), lesions extended into the periphery of the follicles
(Fig. 2 B). These lesions were identical to those previously
reported for several strains of mice (7). In contrast, IFNR/ mice showed infective lesions with a considerably
reduced number of TUNEL nuclei (Fig. 2 D and Table I).
Examination at 24 h after infection showed minor changes

Table I. Spleens Examined 48 h after the Indicated Dose of Listeria
L. monocytogenes
dose
Mice

n

5  103
5  103
2.5  104
2.5  104
5  104
5  104

4 30–50% - severe
5
10% - mild
4 50–100% - severe
5
10% - mild
5 75–100% - severe
6
20% - mild

WT
IFN-R
WT
IFN-R
WT
IFN-R

Pathology
(48 h)

Apoptosis
(48 h)
3
1
4
1
4
1–2

In pathology, the percentage refers to the number of white pulp profiles
showing the lesions. Severe means extensive depletion of lymphocytes,
mostly in the periarteriolar lymphoid sheath but extending to peripheral
areas of the pulp. Mild refers to a slight reduction localized to the
periarteriolar lymphoid sheath. TUNEL analysis shows varying numbers
of positive nuclei. Slides were scored blindly by one of us.
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Figure 2. Histologic analysis of 129Sv/Ev and IFN-R mice infected with L. monocytogenes. 129Sv/Ev (A and B) and IFN-R/ (C
and D) mice were infected with 5  104 Listeria intraperitoneally and
spleens were removed and stained by either hematoxylin and eosin
(H&E) (A and C) or by TUNEL (B and D) 48 h later. Each panel shows
one white pulp profile stained by hematoxylin and eosin and the corresponding profile stained by TUNEL. Pictures are representative profiles
from five mice per group. Bars, 50 m.

in the periarteriolar lymphoid sheath and only occasional
TUNEL cells in both strains of mice.
Analysis of cytokines in the serum of infected mice at
24 h after infection, a time when there was no difference in
Listeria load, showed an equal increase in both IL-6 (Fig. 1
C) and IFN- (Fig. 1 E) in both strains. However, the concentration of IL-12 was markedly higher in the IFN-R/
mice (Fig. 1 F). The elevated level of IL-12 is consistent
with published data showing that type I IFN signaling resulted in the down-regulation of IL-12 expression (11). The
cytokine profiles at 48 and 96 h shown in Fig. 1, C–F, likely
reflect the extent of infection in each strain (i.e., wild-type
mice showed continued Listeria growth, whereas IFNR/ mice showed a limited Listeria burden).
During early Listeria infection, one sees a nonspecific
stage of T lymphocyte activation, made evident by the upregulation of CD69 cell surface expression (8). It has also
been shown that type I IFN signaling can induce CD69
expression on T cells (12). Moreover, in vivo Listeria infection induces type I IFN production (13, 14) and, in vitro,
Listeria-infected macrophages produce type I IFN after
detecting the presence of an intracellular pathogen (15).
Therefore, we assayed Listeria-infected wild-type and IFNR/ mice for the percentage of CD4 and CD8 T cells
expressing CD69. Infected wild-type mice showed a threeto sixfold increase in the number of CD69 T cells in their
spleens, whereas the increase in infected IFN-R/
mice was only two- to threefold. In uninfected 129Sv/Ev
mice, 4% of the CD8 T cells were CD69 . This number
increased to 13 and 25% at days 1 and 2 after infection, respectively. In uninfected IFN-R/ mice, 4% of the
CD8 T cells were CD69 , which increased to 8 and 12%
at days 1 and 2, respectively. The picture was similar for
CD4 T cells, where in 129Sv/Ev mice, 10% of the CD4
cells were CD69 before infection, 18% were CD69 at
day 1, and 30% were CD69 at day 2 after infection. In
IFN-R/ mice, 8% of the CD4 cells were CD69 in
the uninfected mouse, with 10% CD69 at day 1 and 15%
CD69 at day 2 after infection. This difference in CD69
may reflect a higher level of activation of T lymphocytes in
wild-type mice, a step which could enhance their susceptibility to Listeria-induced apoptosis.
Response of T Cells to LLO in Culture. We demonstrated
previously that treatment with sublytic doses of LLO induced apoptosis in T cells (9). In that study, we observed a
difference in the extent of apoptosis between resting lymphocytes and those recently activated by exposure to antigen. Because type I IFN is produced early during Listeria infection (13–15), we hypothesized that the early burst of IFN
could enhance the susceptibility of lymphocytes to apoptosis.
We chose to monitor apoptosis in lymphocytes treated
with type I IFN by flow cytometry using annexin V that
binds to phosphatidylserine exposed on the outer leaflet of
the plasma membrane, and 7-AAD, which measures nuclear
permeability. This assay distinguishes apoptotic cells, which
stain with annexin V but not 7-AAD, from late apoptotic or
necrotic cells, which stain positive for both markers.
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We first tested CD4 T lymphocytes from ex vivo culture
10 d after antigen stimulation by incubating them in the
presence or absence of IFN-A for 24 h, and then exposing
them to 250 ng/ml LLO for 6 h. We selected this time point
on the basis of previous kinetic studies on cultured T cells
treated with LLO (9). In the absence of LLO, 8–10% of cells
underwent apoptosis (i.e., became annexin V /7-AAD).
6 h of treatment with LLO increased this number to 22%,
in accordance with our previous study (Fig. 3, A, D, and J;
reference 9). The set of cells staining with both annexin V
and 7-AAD also increased upon LLO treatment. Our previous study demonstrated that LLO-treated cells shifted over
time from the single positive (annexin V /7-AAD) to the
double positive (annexin V /7-AAD ), the latter of which
contains late apoptotic as well as necrotic cells (9).
Treatment with IFN-A alone did not significantly
increase the number of apoptotic cells. Annexin V /7AAD cells constituted, on average, 8, 8, and 10% of the
cells after treatment with 1, 10, and 100 U/ml IFN-A, respectively (Fig. 3 J). However, treatment with IFN-A
augmented the number of cells undergoing LLO-induced
apoptosis, in a dose-dependent manner. Cells treated with
1, 10, and 100 U/ml IFN-A and then exposed to 250 ng/
538

ml LLO had annexin V /7-AAD populations of 29, 38,
and 43%, respectively (Fig. 3, G and J).
To extend our results to primary cells, we isolated splenocytes, cultured them for 24 h in increasing doses of IFNA, treated them with LLO, and assayed them for apoptosis by annexin V/7-AAD staining. As an average, 13% of
untreated CD3 cells were annexin V /7-AAD (Fig. 3, B
and K). This number increased to 24% upon LLO treatment (Fig. 3, E and K). The addition of type I IFN increased the response of T cells to LLO-induced apoptosis
in a dose-dependent manner. At the highest IFN-A dose
tested (100 U/ml), 37% of cells CD3 became annexin
V /7-AAD (Fig. 3, H and K). This increase, albeit modest, was highly reproducible in three experiments. In contrast, type I IFN did not increase LLO-induced apoptosis in
splenocytes isolated from IFN-R/ mice. The percentage increase in annexin V /7-AAD cells taken from IFNR/ spleen after treatment with LLO was the same in
the absence of IFN-A (Fig. 3, F and L) and at all doses of
IFN-A tested (Fig. 3, I and L).
(Spleen cells from wild-type mice cultured for 2, 4, and
6 h with LLO resulted in 26, 29, and 24% of annexin V /
7-AAD cells, respectively. The addition of IFN-A in-
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Figure 3. Annexin V/7-AAD
analysis of LLO-treated lymphocytes. A cultured, resting T cell line
(A, D, G, and J) and 129Sv/Ev splenocytes (B, E, H, and K) or IFNR/ splenocytes (C, F, I, and L)
were either untreated (A–C), treated
with 250 ng/ml LLO (D–F), or
treated with 250 ng/ml LLO after
24 h of treatment with 100 U/ml
IFN-A (G–I). Cells were stained
for annexin V/7-AAD. For the
spleen, data is gated on CD3 events
only. The flow cytometry plots
shown in A–I are representative of
two to three experiments. J–L show
the average result of two experiments with the cell line and three
with the splenocytes, each performed in duplicate or triplicate. J–L
show the percentage of annexin V /
7-AAD cultured cells after the indicated treatments. Although their
number is related with responsiveness to IFN-A, the double positive
cells taken from the spleen are not,
probably because they represent a
mixture of cells varying in their in
vitro susceptibility. J, T cell line; K,
wild-type spleen cells; L, IFNR/ spleen cells. Asterisks indicates statistical significance at a
p-value of 0.0001 (*) or 0.0041
(**) by unpaired t test.
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clude Toll-like receptor (TLR)4 or TLR9 agonists such as
lipoteichoic acid or CpG DNA motifs, which have been
shown to induce type I IFN expression by dendritic cells
(23). Analysis of TLR4/, TLR9/, and MyD88/
mice or cells may yield insight into the generation of type I
IFN in response to Listeria infection. Macrophages recognizing cytosolic Listeria also generate IFN- (15), suggesting this cell type as a source for the cytokine. Alternatively,
Listeria could generate proteins that promote expression of
type I IFN to enhance its virulence and dissemination.
A classical role ascribed to type I IFN signaling is the enhancement of cancer cell and virus-infected cell apoptosis.
One possible mechanism for type I IFN’s sensitization of T
cells to undergo apoptosis would be the accumulation of the
p53 tumor suppressor gene (24). After p53 expression, cellular stress caused by LLO disruption of the plasma membrane
might then lead to apoptosis induction. Further studies will
examine the role of type I IFNs in LLO-induced apoptosis.
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